Summary
- Current Price
- As of today, RCKT price is $4.73, down -3.86% on
- Current Price All-Time High
- RCKT price is currently -93.92% below its historical high of $77.80 set on
- Market Cap
- RCKT current market cap is $512M, down -43.52% year-over-year
- PE Ratio
- RCKT PE ratio is unknown
- Revenue
- RCKT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RCKT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rocket Pharmaceuticals, Inc. |
| Ticker | NASDAQ: RCKT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rocketpharma.com |
| Employees | 299 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.73 | |
| Price, 1D Change | -3.86% | |
| $512M | ||
| - | ||
| - | ||
| 1.21 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.01 | ||
| EPS, 1Y Change | +26.43% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ITEK | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.01 | ||
| EPS Estimate | N/A | -$1.06 |
| EPS Est. Change | N/A | +47.21% |
| $0.00 | ||
| Revenue Estimate | N/A | $15.25M |
| Revenue Est. Change | N/A | - |
| Current Price | $4.73 | |
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +90.27% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.80 | -$2.73 | +2.69% | |
| -$2.01 | -$2.01 | +0.28% | |
| -$1.06 | N/A | +47.21% | |
| -$1.21 | N/A | +39.65% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $28.45K | $0.00 | -100.00% | |
| - | $0.00 | - | |
| $15.25M | N/A | - | |
| $21.05M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.73 | |
| $3.38 | ||
| SMA 200 vs Price | -28.55% | |
| $3.89 | ||
| SMA 50 vs Price | -17.69% | |
| 1.21 | ||
| $0.37 | ||
| 58.14 | ||
| 102.05% | ||
| 108.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.01 | ||
| $0.00 | ||
| - | ||
| -$228.52M | ||
| - | ||
| -$223.12M | ||
| - | ||
| -$217.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.09 | ||
| 6.38 | ||
| 6.38 | ||
| - | ||
| - | ||
| 0.25 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.85 | ||
| -1.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $277.22M | ||
| $188.93M | ||
| $330.45M | ||
| $192.73M | ||
| $53.23M | ||
| $30.21M | ||
| $24.88M | ||
| $2.92M | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $223.12M | ||
| $217.49M | ||
| $11.03M | ||
| $86.50M | ||
| $11.03M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$190.05M | ||
| $103.77M | ||
| $183.00K | ||
| $440.00K | ||
| -$190.49M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Goldman Sachs | → | |
| Cantor Fitzgerald | → | |
| JP Morgan | → | |
| B of A Securities | → | |
| Chardan Capital | → | |
| Leerink Partners | → | |
| Chardan Capital | → | |
| B of A Securities | → | |
| Chardan Capital | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with RCKT
FAQ
What is the ticker symbol for Rocket Pharmaceuticals, Inc.?
The ticker symbol for Rocket Pharmaceuticals, Inc. is NASDAQ:RCKT
Does Rocket Pharmaceuticals, Inc. pay dividends?
No, Rocket Pharmaceuticals, Inc. does not pay dividends
What sector is Rocket Pharmaceuticals, Inc. in?
Rocket Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Rocket Pharmaceuticals, Inc. in?
Rocket Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Rocket Pharmaceuticals, Inc. based in?
Rocket Pharmaceuticals, Inc. is headquartered in United States
When did Rocket Pharmaceuticals, Inc. go public?
Rocket Pharmaceuticals, Inc. initial public offering (IPO) was on February 18, 2015
Is Rocket Pharmaceuticals, Inc. in the S&P 500?
No, Rocket Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Rocket Pharmaceuticals, Inc. in the NASDAQ 100?
No, Rocket Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Rocket Pharmaceuticals, Inc. in the Dow Jones?
No, Rocket Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Rocket Pharmaceuticals, Inc. last earnings report?
Rocket Pharmaceuticals, Inc.'s most recent earnings report was on February 26, 2026
When does Rocket Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Rocket Pharmaceuticals, Inc. is May 7, 2026
Data Sources & References
- RCKT Official Website www.rocketpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1281895/000119312526076551/0001193125-26-076551-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1281895/000119312526076551/0001193125-26-076551-index.htm
- RCKT Profile on Yahoo Finance finance.yahoo.com/quote/RCKT
- RCKT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rckt